D. Spirk

发表

Predictors of in-hospital mortality in elderly patients with acute venous thrombo-embolism: the SWIss Venous ThromboEmbolism Registry (SWIVTER).

D. Hayoz, B. Frauchiger, N. Kucher, 2012, European heart journal.

Use of biomarkers or echocardiography in pulmonary embolism: the Swiss Venous Thromboembolism Registry.

D. Aujesky, D. Hayoz, N. Kucher, 2012, QJM : monthly journal of the Association of Physicians.

Cardiac troponin testing and the simplified Pulmonary Embolism Severity Index

D. Aujesky, D. Hayoz, B. Frauchiger, 2011, Thrombosis and Haemostasis.

Clinical predictors of prophylaxis use prior to the onset of acute venous thromboembolism in hospitalized patients SWIss Venous ThromboEmbolism Registry (SWIVTER)

L. Mazzolai, B. Frauchiger, N. Kucher, 2008, Journal of thrombosis and haemostasis : JTH.

DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.

A. Miserez, D. Spirk, F. J. Martin, 2018, Atherosclerosis.

Clinical Outcomes of Venous Thromboembolism in Patients with and without Cancer: The SWIss Venous ThromboEmbolism Registry (SWIVTER)

L. Mazzolai, D. Aujesky, D. Hayoz, 2016, Seminars in Thrombosis and Hemostasis.

Lack of prophylaxis before the onset of acute venous thromboembolism among hospitalized cancer patients: the SWIss Venous ThromboEmbolism Registry (SWIVTER).

L. Mazzolai, N. Kucher, I. Baumgartner, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Hypertension Control and Cardiometabolic Risk: A Regional Perspective

M. Volpe, P. Bramlage, M. Thoenes, 2012, Cardiology research and practice.

Multicentre validation of the Geneva Risk Score for hospitalised medical patients at risk of venous thromboembolism

D. Aujesky, D. Hayoz, B. Frauchiger, 2013, Thrombosis and Haemostasis.

Clinical efficacy and safety of enoxaparin in unselected Swiss patients undergoing primary or elective percutaneous coronary intervention: Analysis of the RIVIERA study

N. Kucher, D. Spirk, M. Pieper, 2009, Acta cardiologica.

Clinical Outcomes of Incidental Venous Thromboembolism in Cancer and Noncancer Patients: The SWIss Venous ThromboEmbolism Registry (SWIVTER)

L. Mazzolai, D. Aujesky, D. Hayoz, 2020, Thrombosis and Haemostasis.

Treatment intensification with insulin glargine in patients with inadequately controlled type 2 diabetes improves glycaemic control with a high treatment satisfaction and no weight gain.

R. Lehmann, D. Spirk, L. Villiger, 2015, Swiss medical weekly.

First Line CombinAtion Therapy in the Treatment of Stage II and III Hypertension (FLASH)

M. Burnier, S. Rimoldi, G. Noll, 2020, Frontiers in Cardiovascular Medicine.

Comparative Performance of Clinical Risk Assessment Models for Hospital-Acquired Venous Thromboembolism in Medical Patients

D. Aujesky, D. Hayoz, B. Frauchiger, 2018, Thrombosis and Haemostasis.

Venous Thromboembolism and Renal Impairment: Insights from the SWIss Venous ThromboEmbolism Registry (SWIVTER)

L. Mazzolai, D. Aujesky, D. Hayoz, 2019, Seminars in Thrombosis and Hemostasis.

Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial

N. Kucher, G. Colucci, M. Schindewolf, 2022, The Lancet Haematology.

Effects of the PCSK9 Antibody Alirocumab on Coronary Atherosclerosis in Patients with Acute Myocardial Infarction: A Serial, Multivessel, Intravascular Ultrasound, Near-Infrared Spectroscopy and Optical Coherence Tomography Imaging Study Rationale and Design of the PACMAN-AMI trial.

L. Räber, S. Windecker, F. Mach, 2021, American heart journal.

Fixed low-dose ultrasound-assisted catheter-directed thrombolysis followed by routine stenting of residual stenosis for acute ilio-femoral deep-vein thrombosis

N. Kucher, J. Fahrni, R. Engelberger, 2014, Thrombosis and Haemostasis.

Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE)

G. Ehret, A. Delabays, S. Bodenmann, 2022, Frontiers in Cardiovascular Medicine.

Predictors of thromboprophylaxis in hospitalised medical patients

D. Aujesky, D. Hayoz, B. Frauchiger, 2015, Thrombosis and Haemostasis.

Rivaroxaban or vitamin-K antagonists following early endovascular thrombus removal and stent placement for acute iliofemoral deep vein thrombosis.

N. Kucher, R. Engelberger, M. Banyai, 2018, Thrombosis research.

Rivaroxaban for the treatment of venous thromboembolism

L. Mazzolai, D. Aujesky, D. Hayoz, 2016, Thrombosis and Haemostasis.

Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial.

L. Räber, S. Windecker, R. V. van Geuns, 2022, JAMA.

Cessation of anticoagulation therapy following endovascular thrombus removal and stent placement for acute iliofemoral deep vein thrombosis.

N. Kucher, R. Engelberger, F. Baumann, 2019, VASA. Zeitschrift fur Gefasskrankheiten.

The Modified Ottawa Score and Clinical Events in Hospitalized Patients with Cancer-Associated Thrombosis from the Swiss VTE Registry

L. Mazzolai, D. Aujesky, D. Hayoz, 2017, Seminars in Thrombosis and Hemostasis.

Risk assessment models for venous thromboembolism in acutely ill medical patients. A systematic review.

N. Kucher, D. Spirk, A. Stuck, 2017, Thrombosis and haemostasis.

Lack of extended venous thromboembolism prophylaxis in high-risk patients undergoing major orthopaedic or major cancer surgery

K. Siebenrock, N. Kucher, U. Metzger, 2009, Thrombosis and Haemostasis.

Electronic alert system for improving appropriate thromboprophylaxis in hospitalized medical patients: a randomized controlled trial

D. Aujesky, N. Kucher, R. Engelberger, 2017, Journal of thrombosis and haemostasis : JTH.

Identifying acutely ill medical patients requiring thromboprophylaxis

P. Chopard, H. Bounameaux, D. Spirk, 2006, Journal of thrombosis and haemostasis : JTH.

Swiss results from a global observational study of venous thromboembolism risk and prophylaxis use in the acute care hospital setting: analysis from the ENDORSE study.

P. Chopard, H. Bounameaux, D. Spirk, 2009, Swiss medical weekly.

Incidence of Stent Thrombosis after Endovascular Treatment of Iliofemoral or Caval Veins in Patients with the Postthrombotic Syndrome

N. Kucher, R. Engelberger, F. Baumann, 2019, Thrombosis and Haemostasis.

Inconsistencies in the planning of the duration of anticoagulation among outpatients with acute deep-vein thrombosis

N. Kucher, I. Baumgartner, M. Banyai, 2010, Thrombosis and Haemostasis.

Impact of concomitant popliteal vein thrombosis in patients with acute iliofemoral deep vein thrombosis treated with endovascular early thrombus removal.

D. Hayoz, N. Kucher, D. Betticher, 2022, VASA. Zeitschrift fur Gefasskrankheiten.

Role of age, sex, and specific provoking factors on the distal versus proximal presentation of first symptomatic deep vein thrombosis: analysis of the SWIss Venous ThromboEmbolism Registry (SWIVTER)

L. Mazzolai, D. Aujesky, D. Hayoz, 2021, Internal and Emergency Medicine.

Ultrasound‐assisted versus conventional catheter‐directed thrombolysis for acute iliofemoral deep vein thrombosis: 1‐year follow‐up data of a randomized‐controlled trial

N. Kucher, R. Engelberger, I. Baumgartner, 2017, Journal of thrombosis and haemostasis : JTH.

Long-term anticoagulation treatment for acute venous thromboembolism in patients with and without cancer

D. Aujesky, D. Hayoz, B. Frauchiger, 2011, Thrombosis and Haemostasis.

Differences in duration of anticoagulation after pulmonary embolism and deep vein thrombosis: Findings from the SWIss Venous ThromboEmbolism Registry (SWIVTER).

L. Mazzolai, D. Aujesky, D. Hayoz, 2022, Thrombosis research.

A nation-wide initiative against venous thromboembolism.

N. Kucher, H. Bounameaux, D. Spirk, 2011, Swiss medical weekly.

Outpatient management of acute deep vein thrombosis: results from the OTIS-DVT registry.

N. Kucher, I. Baumgartner, M. Banyai, 2011, Thrombosis research.

Self-Expandable Nitinol Stents for the Treatment of Nonmalignant Deep Venous Obstruction

N. Kucher, R. Engelberger, C. Lodigiani, 2020, Circulation. Cardiovascular interventions.

Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registry

N. Kucher, R. Arya, J. Beyer-Westendorf, 2022, Research and practice in thrombosis and haemostasis.

Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial

N. Kucher, G. Colucci, R. Bingisser, 2022, Thrombosis Research.

False versus True Statin Intolerance in Patients with Peripheral Artery Disease

H. Drexel, D. Spirk, J. Dopheide, 2022, Journal of clinical medicine.

Outcomes of endovascular reconstruction of the inferior vena cava with self-expanding nitinol stents.

N. Kucher, R. Engelberger, T. Sebastian, 2018, Journal of vascular surgery. Venous and lymphatic disorders.

Prevalent use of high-intensity statin therapy and LDL-C target attainment among PAD patients undergoing angioplasty.

N. Kucher, T. Sebastian, S. Barco, 2022, VASA. Zeitschrift fur Gefasskrankheiten.

A novel management strategy for treatment of pelvic venous disorders utilizing a clinical screening score and non-invasive imaging.

N. Kucher, T. Sebastian, S. Barco, 2022, VASA. Zeitschrift fur Gefasskrankheiten.

Electronic Alert System for Improving Stroke Prevention Among Hospitalized Oral‐Anticoagulation‐Naïve Patients With Atrial Fibrillation: A Randomized Trial

Nils Kucher, Günther Silbernagel, N. Kucher, 2016, Journal of the American Heart Association.

Ultrasound-Assisted Versus Conventional Catheter-Directed Thrombolysis for Acute Iliofemoral Deep Vein Thrombosis

N. Kucher, R. Engelberger, I. Baumgartner, 2015, Circulation. Cardiovascular interventions.

Treatment of hypertension in the elderly: data from an international cohort of hypertensives treated by cardiologists

M. Böhm, F. Mahfoud, P. Bramlage, 2013, Journal of Human Hypertension.

Global reporting of pulmonary embolism–related deaths in the World Health Organization mortality database: Vital registration data from 123 countries

W. Ageno, S. Goldhaber, N. Kucher, 2021, Research and practice in thrombosis and haemostasis.

Risk assessment models for venous thromboembolism in acutely ill medical patients

N. Kucher, D. Spirk, A. Stuck, 2017, Thrombosis and Haemostasis.

Pulmonary embolism and deep vein thrombosis: Similar but different.

N. Kucher, R. Engelberger, T. Sebastian, 2021, Thrombosis Research.

Adequacy of venous thromboprophylaxis in acutely ill medical patients (IMPART): multisite comparison of different clinical decision support systems

C. Lovis, N. Kucher, L. Asmis, 2010, Journal of thrombosis and haemostasis : JTH.

Hans-jurg Beer Repository Citation

P. Chopard, H. Bounameaux, D. Spirk, 2022 .

In vivo relationship between near-infrared spectroscopy-detected lipid-rich plaques and morphological plaque characteristics by optical coherence tomography and intravascular ultrasound: a multimodality intravascular imaging study.

L. Räber, K. Koskinas, T. Engstrøm, 2020, European heart journal cardiovascular Imaging.

Mortality rate related to peripheral arterial disease: A retrospective analysis of epidemiological data (years 2008-2019).

N. Kucher, U. Fedeli, E. Schievano, 2022, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Effect of Home Blood Pressure Monitoring on Patient’s Awareness and Goal Attainment Under Antihypertensive Therapy: The Factors Influencing Results in Anti-HypertenSive Treatment (FIRST) Study

M. Burnier, S. Rimoldi, G. Noll, 2018, Kidney and Blood Pressure Research.

Regional differences of glycaemic control in patients with type 2 diabetes mellitus in Switzerland: a national cross-sectional survey.

R. Lehmann, M. Brändle, U. Keller, 2011, Swiss medical weekly.

Duplex Ultrasound Investigation for the Detection of Obstructed Iliocaval Venous Stents.

N. Kucher, M. Schindewolf, R. Engelberger, 2020, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

Impact of alirocumab on plaque regression and haemodynamics of non-culprit arteries in patients with acute myocardial infarction: a prespecified substudy of the PACMAN-AMI trial.

L. Räber, S. Windecker, T. Engstrøm, 2023, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trials.

W. Ageno, R. Lopes, N. Kucher, 2023, Thrombosis research.

Effect of Alirocumab Added to High-Intensity Statin on Platelet Reactivity and Noncoding RNAs in Patients with AMI: A Substudy of the PACMAN-AMI Trial

M. Mayr, L. Räber, S. Windecker, 2023, Thrombosis and Haemostasis.

Concomitant Coronary Atheroma Regression and Stabilization in Response to Lipid-Lowering Therapy.

L. Räber, S. Windecker, R. V. van Geuns, 2023, Journal of the American College of Cardiology.

Effects of alirocumab on endothelial function and coronary atherosclerosis in myocardial infarction: A PACMAN-AMI randomized clinical trial substudy.

L. Räber, G. Siontis, T. Otsuka, 2024, Atherosclerosis.